Michel Ghilezan

1.3k total citations
29 papers, 1.0k citations indexed

About

Michel Ghilezan is a scholar working on Pulmonary and Respiratory Medicine, Radiation and Biomedical Engineering. According to data from OpenAlex, Michel Ghilezan has authored 29 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Pulmonary and Respiratory Medicine, 21 papers in Radiation and 5 papers in Biomedical Engineering. Recurrent topics in Michel Ghilezan's work include Prostate Cancer Diagnosis and Treatment (22 papers), Advanced Radiotherapy Techniques (21 papers) and Prostate Cancer Treatment and Research (16 papers). Michel Ghilezan is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (22 papers), Advanced Radiotherapy Techniques (21 papers) and Prostate Cancer Treatment and Research (16 papers). Michel Ghilezan collaborates with scholars based in United States, Netherlands and Canada. Michel Ghilezan's co-authors include Alvaro A. Martinez, D. Jeffrey Demanes, Gary Gustafson, Di Yan, Lionel Schour, Frank A. Vicini, Carlos Vargas, Larry L. Kestin, David A. Jaffray and Jian Liang and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Urology and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Michel Ghilezan

29 papers receiving 980 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michel Ghilezan United States 14 742 681 224 142 122 29 1.0k
Raxa Sankreacha Canada 13 405 0.5× 471 0.7× 168 0.8× 127 0.9× 55 0.5× 27 699
S Leibel United States 16 777 1.0× 602 0.9× 369 1.6× 58 0.4× 52 0.4× 45 984
Måns Agrup Sweden 5 589 0.8× 422 0.6× 193 0.9× 57 0.4× 25 0.2× 15 759
Gyoergy Kovács Germany 8 413 0.6× 285 0.4× 63 0.3× 109 0.8× 27 0.2× 13 570
André‐Guy Martin Canada 19 774 1.0× 504 0.7× 176 0.8× 46 0.3× 138 1.1× 90 1.0k
Laura Van den Bergh Belgium 13 1.1k 1.4× 364 0.5× 462 2.1× 50 0.4× 60 0.5× 37 1.2k
Anthony Neal United Kingdom 13 213 0.3× 343 0.5× 214 1.0× 265 1.9× 28 0.2× 23 573
Peter-Paul van der Toorn Netherlands 8 457 0.6× 368 0.5× 166 0.7× 86 0.6× 43 0.4× 14 634
Elantholi P. Saibishkumar Canada 14 306 0.4× 284 0.4× 140 0.6× 45 0.3× 51 0.4× 28 538
Joe H. Chang Australia 13 326 0.4× 254 0.4× 253 1.1× 51 0.4× 38 0.3× 21 604

Countries citing papers authored by Michel Ghilezan

Since Specialization
Citations

This map shows the geographic impact of Michel Ghilezan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michel Ghilezan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michel Ghilezan more than expected).

Fields of papers citing papers by Michel Ghilezan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michel Ghilezan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michel Ghilezan. The network helps show where Michel Ghilezan may publish in the future.

Co-authorship network of co-authors of Michel Ghilezan

This figure shows the co-authorship network connecting the top 25 collaborators of Michel Ghilezan. A scholar is included among the top collaborators of Michel Ghilezan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michel Ghilezan. Michel Ghilezan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Demanes, D. Jeffrey & Michel Ghilezan. (2014). High-dose-rate brachytherapy as monotherapy for prostate cancer. Brachytherapy. 13(6). 529–541. 81 indexed citations
4.
Marina, Ovidiu, Gary Gustafson, Larry L. Kestin, et al.. (2013). Comparison of dose-escalated, image-guided radiotherapy vs. dose-escalated, high-dose-rate brachytherapy boost in a modern cohort of intermediate-risk prostate cancer patients. Brachytherapy. 13(1). 59–67. 21 indexed citations
5.
Ghilezan, Michel, Alvaro A. Martinez, Daniel Krauss, et al.. (2011). High-Dose-Rate Brachytherapy as Monotherapy Delivered in Two Fractions Within One Day for Favorable/Intermediate-Risk Prostate Cancer: Preliminary Toxicity Data. International Journal of Radiation Oncology*Biology*Physics. 83(3). 927–932. 68 indexed citations
6.
Krauss, Daniel, Mitual Amin, Hong Ye, et al.. (2011). Prognostic Significance of Neuroendocrine Differentiation in Patients With Gleason Score 8–10 Prostate Cancer Treated With Primary Radiotherapy. International Journal of Radiation Oncology*Biology*Physics. 81(3). e119–e125. 25 indexed citations
7.
Demanes, D. Jeffrey, Alvaro A. Martinez, Michel Ghilezan, et al.. (2011). High-Dose-Rate Monotherapy: Safe and Effective Brachytherapy for Patients With Localized Prostate Cancer. International Journal of Radiation Oncology*Biology*Physics. 81(5). 1286–1292. 131 indexed citations
8.
Martinez, Alvaro A., J. Demanes, Carlos Vargas, et al.. (2010). High-Dose-Rate Prostate Brachytherapy. American Journal of Clinical Oncology. 33(5). 481–488. 122 indexed citations
9.
Mohammed, Nasiruddin, Michel Ghilezan, Larry L. Kestin, et al.. (2010). High-Dose-Rate Re-Irradiation with Continuous Hyperthermia for Recurrent Prostate Cancer. Brachytherapy. 9. S72–S72. 1 indexed citations
10.
Krauss, Daniel, Larry L. Kestin, Hong Ye, et al.. (2010). Lack of Benefit for the Addition of Androgen Deprivation Therapy to Dose-Escalated Radiotherapy in the Treatment of Intermediate- and High-Risk Prostate Cancer. International Journal of Radiation Oncology*Biology*Physics. 80(4). 1064–1071. 50 indexed citations
11.
Ghilezan, Michel, Di Yan, & Alvaro A. Martinez. (2010). Adaptive Radiation Therapy for Prostate Cancer. Seminars in Radiation Oncology. 20(2). 130–137. 74 indexed citations
12.
Park, Sean S., Inga S. Grills, Peter Y. Chen, et al.. (2010). Accelerated Partial Breast Irradiation for Pure Ductal Carcinoma in Situ. International Journal of Radiation Oncology*Biology*Physics. 81(2). 403–408. 27 indexed citations
13.
Park, Sean S., Inga S. Grills, Larry L. Kestin, et al.. (2010). Accelerated Partial Breast Irradiation for Pure Ductal Carcinoma In Situ. Brachytherapy. 9. S39–S39. 1 indexed citations
14.
Tyagi, Neelam, Evelyn Sebastian, Jian Liang, et al.. (2010). Deformable Registration and Dose Accumulation for Image-guided HDR Interstitial Brachytherapy (IG-BT) Boost and External Beam Pelvic IMRT (EB-IMRT) for Intermediate and High-risk Prostate Cancer Patients. International Journal of Radiation Oncology*Biology*Physics. 78(3). S731–S732. 1 indexed citations
15.
McGrath, Samuel, J. Vito Antonucci, Dwight L. Fitch, et al.. (2009). PSA bounce after prostate brachytherapy with or without neoadjuvant androgen deprivation. Brachytherapy. 9(2). 137–144. 17 indexed citations
16.
Chao, K., Frank A. Vicini, Michelle Wallace, et al.. (2007). Analysis of Treatment Efficacy, Cosmesis, and Toxicity Using the MammoSite Breast Brachytherapy Catheter to Deliver Accelerated Partial-Breast Irradiation: The William Beaumont Hospital Experience. International Journal of Radiation Oncology*Biology*Physics. 69(1). 32–40. 104 indexed citations
17.
Chao, K., Neal S. Goldstein, Di Yan, et al.. (2006). Clinicopathologic analysis of extracapsular extension in prostate cancer: Should the clinical target volume be expanded posterolaterally to account for microscopic extension?. International Journal of Radiation Oncology*Biology*Physics. 65(4). 999–1007. 70 indexed citations
18.
Vicini, Frank A., Larry L. Kestin, Michel Ghilezan, & Alvaro A. Martinez. (2006). Radiation dose for prostate cancer: is more better?. Nature Clinical Practice Oncology. 3(6). 298–299. 3 indexed citations
19.
Vargas, Carlos, Michel Ghilezan, Gary Gustafson, et al.. (2005). A NEW MODEL USING NUMBER OF NEEDLES AND ANDROGEN DEPRIVATION TO PREDICT CHRONIC URINARY TOXICITY FOR HIGH OR LOW DOSE RATE PROSTATE BRACHYTHERAPY. The Journal of Urology. 174(3). 882–887. 37 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Raxa Sankreacha Breakdown of academic impact, for papers by S Leibel Breakdown of academic impact, for papers by Måns Agrup Breakdown of academic impact, for papers by Gyoergy Kovács Breakdown of academic impact, for papers by André‐Guy Martin Breakdown of academic impact, for papers by Laura Van den Bergh Breakdown of academic impact, for papers by Anthony Neal Breakdown of academic impact, for papers by Peter-Paul van der Toorn Breakdown of academic impact, for papers by Elantholi P. Saibishkumar Breakdown of academic impact, for papers by Joe H. Chang
Rankless by CCL
2026